Research Articles | Page 94 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Laboratory tests for paroxysmal nocturnal hemoglobinuria (PNH). Oct 2013 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes Apr 2014 Am J Hematol myelodysplastic syndromes (MDS)
Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry Jan 2019 Am J Hematol aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH)
Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria Jan 2018 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management Jul 2012 Am J Hematol myelodysplastic syndromes (MDS)
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes Aug 2012 Am J Hematol myelodysplastic syndromes (MDS)
An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes Mar 2017 Am J Hematol myelodysplastic syndromes (MDS)
Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia Jan 2014 Am J Hematol aplastic anemia
High levels of vascular endothelial growth factor protein expression are associated with an increased risk of transfusion dependence in myelodysplastic syndromes Mar 2013 Am J Clin Pathol myelodysplastic syndromes (MDS)
Mesenchymal stromal cell density is increased in higher grade myelodysplastic syndromes and independently predicts survival Dec 2014 Am J Clin Pathol myelodysplastic syndromes (MDS)